Printer Friendly
The Free Library
14,588,244 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Guidant gains FDA approval to market new guide wire exchange device.


INDIANAPOLIS--(HealthWire)--April 11, 1996--Guidant Corp. (NYSE NYSE

See: New York Stock Exchange
 and PSE PSE

1. pale soft exudative pork.

2. portosystemic encephalopathy.
:GDT), a worldwide leader in percutaneous transluminal coronary angioplasty percutaneous transluminal coronary angioplasty
n. Abbr. PTCA
A procedure for enlarging a narrowed arterial lumen by peripheral introduction of a balloon-tip catheter followed by dilation of the lumen as the inflated catheter tip is
 (PTCA PTCA
abbr.
percutaneous transluminal coronary angioplasty


PTCA Percutaneous transluminal coronary angioplasty, see there
) and atherectomy, today announced that it has received U.S. Food and Drug Administration (FDA) approval to market the ACS ANCHOR(TM) Exchange Device in the United States.

Manufactured by Advanced Cardiovascular Systems, Inc. (ACS), part of Guidant's Vascular Intervention group, the ACS ANCHOR is used to exchange devices during interventional procedures. The ability for a quick exchange is important since it is often necessary for a physician to use several devices during a single procedure.

The ACS ANCHOR is compatible with balloon dilatation catheters, stent delivery systems, directional coronary atherectomy directional coronary atherectomy Cardiology A method of coronary revascularization, in which targeted atherosclerotic plaques are excised and removed. See Balloon coronary angioplasty, Coronary revascularization, Stent placement.  devices and intravascular ultrasound systems. It is estimated that nearly three quarters of a million people worldwide undergo PTCA, atherectomy or stenting each year. These procedures, which clear blocked arteries in the heart, provide patients with alternatives that are less costly than open heart surgery with quicker recovery times.

The ACS ANCHOR Exchange Device incorporates revolutionary technology, making it a versatile, easy-to-use over-the-wire exchange device. It features a simple, innovative design that incorporates a kink-resistant core wire that is bonded to a proximal mechanical control handle. This allows the operator to rapidly spin the exchange wire securely around the adjacent guide wire without the need for electronics, and is readily released without wires kinking.

"The technology of this device allows cardiologists and cath lab personnel to potentially decrease their radiation exposure due to the reduced need for fluoroscopy fluoroscopy /flu·o·ros·co·py/ (fldbobr-ros´kah-pe) examination by means of the fluoroscope.

fluo·ros·co·py
n.
Examination by means of a fluoroscope. Also called radioscopy.
 during placement and catheter exchanges," stated Ginger Howard, president of the Vascular Intervention group and a Guidant vice president.

A leader in the medical device industry, Guidant provides innovative, cost-effective products and services to the global cardiology and minimally invasive surgery minimally invasive surgery Laparoscopic surgery, see there. See Laparoscopic cholecystectomy.  marketplaces.

CONTACT: Guidant Corporation

Ronda Prothro, 408/235-3420

Robert E. Allen, 317/971-2031
COPYRIGHT 1996 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1996, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Apr 11, 1996
Words:302
Previous Article:California RailFill Systems expands outreach efforts to the Internet; proposed waste-by-rail system and its rail-served landfill now is sited on the...
Next Article:BHA Group Inc. announces second quarter 1996 unaudited operating results.
Topics:



Related Articles
DVI Stops Shipment of Atherectomy Catheter.
DVI resumes shipment of atherectomy catheter.
FDA approves Guidant's ACS RX LIFESTREAM catheter line extensions; FDA also approves perfusion balloon catheter trial results.
Guidant CPI announces market release of VENTAK P3 implantable defibrillator.
FDA expands Guidant's implantable defibrillator labeling to include MADIT patients.
Guidant Receives FDA Approval to Market New Rapid Exchange Catheter.
FDA APPROVES BROADER USE OF ELECTRICAL HEART DEVICE.(News)
Implanted defibrillators linked to patient deaths and injuries.
New litigation packet aids members pursuing heart device claims.
Scrutiny of defibrillator defects grows.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles